Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y, Drobisch P, Krüger A, William D, Grützmann K, Böthig L, Polster H, Seifert L, Seifert AM, Distler M, Pecqueux M, Riediger C, Plodeck V, Nebelung H, Weber GF, Pilarsky C, Kahlert U, Hinz U, Roth S, Hackert T, Weitz J, Wong FC, Kahlert C. Han Y, et al. Among authors: polster h. J Hematol Oncol. 2023 Feb 3;16(1):7. doi: 10.1186/s13045-023-01404-w. J Hematol Oncol. 2023. PMID: 36737824 Free PMC article.
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment.
Hennig A, Baenke F, Klimova A, Drukewitz S, Jahnke B, Brückmann S, Secci R, Winter C, Schmäche T, Seidlitz T, Bereuter JP, Polster H, Eckhardt L, Schneider SA, Brückner S, Schmelz R, Babatz J, Kahlert C, Distler M, Hampe J, Reichert M, Zeißig S, Folprecht G, Weitz J, Aust D, Welsch T, Stange DE. Hennig A, et al. Among authors: polster h. J Pathol. 2022 Aug;257(5):607-619. doi: 10.1002/path.5906. Epub 2022 May 5. J Pathol. 2022. PMID: 35373359
Comprehensive proteomic profiling of serum extracellular vesicles in patients with colorectal liver metastases identifies a signature for non-invasive risk stratification and early-response evaluation.
Lin K, Baenke F, Lai X, Schneider M, Helm D, Polster H, Rao VS, Ganig N, Wong FC, Seifert L, Seifert AM, Jahnke B, Kretschmann N, Ziemssen T, Klupp F, Schmidt T, Schneider M, Han Y, Weber TF, Plodeck V, Nebelung H, Schmitt N, Korell F, Köhler BC, Riediger C, Weitz J, Rahbari NN, Kahlert C. Lin K, et al. Among authors: polster h. Mol Cancer. 2022 Apr 1;21(1):91. doi: 10.1186/s12943-022-01562-4. Mol Cancer. 2022. PMID: 35365178 Free PMC article. No abstract available.
Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases.
Rao VS, Gu Q, Tzschentke S, Lin K, Ganig N, Thepkaysone ML, Wong FC, Polster H, Seifert L, Seifert AM, Buck N, Riediger C, Weiße J, Gutschner T, Michen S, Temme A, Schneider M, Baenke F, Weitz J, Kahlert C. Rao VS, et al. Among authors: polster h. Oncogene. 2022 Mar;41(12):1809-1820. doi: 10.1038/s41388-022-02218-9. Epub 2022 Feb 9. Oncogene. 2022. PMID: 35140332 Free PMC article.
CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids.
Hennig A, Wolf L, Jahnke B, Polster H, Seidlitz T, Werner K, Aust DE, Hampe J, Distler M, Weitz J, Stange DE, Welsch T. Hennig A, et al. Among authors: polster h. Stem Cells Int. 2019 May 2;2019:1024614. doi: 10.1155/2019/1024614. eCollection 2019. Stem Cells Int. 2019. PMID: 31191661 Free PMC article.
Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer.
Ganig N, Baenke F, Thepkaysone ML, Lin K, Rao VS, Wong FC, Polster H, Schneider M, Helm D, Pecqueux M, Seifert AM, Seifert L, Weitz J, Rahbari NN, Kahlert C. Ganig N, et al. Among authors: polster h. Cancers (Basel). 2021 Mar 17;13(6):1351. doi: 10.3390/cancers13061351. Cancers (Basel). 2021. PMID: 33802764 Free PMC article.
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
Zimmermann C, Distler M, Jentsch C, Blum S, Folprecht G, Zöphel K, Polster H, Troost EGC, Abolmaali N, Weitz J, Baumann M, Saeger HD, Grützmann R. Zimmermann C, et al. Among authors: polster h. Strahlenther Onkol. 2021 Jan;197(1):19-26. doi: 10.1007/s00066-020-01654-4. Epub 2020 Jul 7. Strahlenther Onkol. 2021. PMID: 32638040 Free PMC article. Clinical Trial.